Literature DB >> 3897391

Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes.

M Regnier, P Vaigot, S Michel, M Prunieras.   

Abstract

In early studies, the bullous pemphigoid antigen (BPA) has been localized extracellularly in the lamina lucida in the basement membrane zone. However, trypsin-dissociated basal cells can be tagged with bullous pemphigoid sera (BPS). By immunofluorescence, BPA appears located at the dermal pole of basal cells (BC). This may indicate that when BC are separated from the underlying matrix molecules, chunks of BPA remain attached to them. In the present study, fresh crude initial suspensions (CIS) of epidermal cells were prepared by trypsin-EDTA dissociation. The cells were smeared and air-dried. Polar fluorescent cells (i.e., BC) amounted to 42% +/- 7%. CIS were then passed through a fluorescence-activated cell sorter (FACS). In the fluorescent-positive fractions selected by FACS, 34% +/- 7% only of the BC were present. FACS-negative cell fractions were smeared on glass slides, air-dried, and restained with BPS + fluorescein isothiocyanate; 66% +/- 10% of BC were present in these fractions. This is evidence that trypsin-isolated BC comprise two subpopulations: one with BPA directly accessible, the other not. Viability tests and tissue culture studies indicated that the FACS-positive cell fractions were not viable. BPA was extracted from CIS, FACS-positive, and FACS-negative fractions and immunoblotted against BPS. Identical blots were found. FACS-negative cell fractions were treated with heparitinase, nitrous acid, methanol-chloroform, or EDTA without modifying the number of reacting cells. When BC were treated with Triton X-100 or permeabilized by successive freezings and thawings, the number of positive cells became comparable to those obtained by air-drying smears. Finally, BPA was localized on the intracellular part of hemidesmosomes of BC by immunoelectron microscopy. To see whether BPA was also present extracellularly, suction blisters were raised in minipigs and BPS injected into the blister cavity. BPA was found attached to all cells of the cellular roof but not to the dermal base of the blisters. When pieces of skin kept overnight in cold trypsin were reacted with BPS, BPA was found on both sides (epidermal and dermal) of the split. It is concluded that BPA has two localizations: one extracellular, essentially labile which accumulates at the dermal-epidermal junction; the other essentially stable which remains on the intracellular part of basal cell hemidesmosomes and which can be detected after permeabilization of the cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897391     DOI: 10.1111/1523-1747.ep12276656

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180.

Authors:  G J Giudice; H L Squiquera; P M Elias; L A Diaz
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

3.  Antikeratin 14 monoclonal antibody staining in psoriasis and seborrhoeic keratosis: immunofluorescence and two colour FACS studies.

Authors:  H Wongwaisayawan; T Yoshiike; Y Aikawa; R A Briggaman; H Ogawa
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.

Authors:  J R Stanley; T Tanaka; S Mueller; V Klaus-Kovtun; D Roop
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: studies of subclass distribution and complement activation.

Authors:  R E Jordon; P Xia; W D Geoghegan
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

Review 7.  The latest fashions in skin disease.

Authors:  J M Carroll; L A Goldsmith
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

8.  Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Authors:  L Büdinger; L Borradori; C Yee; R Eming; S Ferencik; H Grosse-Wilde; H F Merk; K Yancey; M Hertl
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

9.  Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen.

Authors:  L H Morrison; R S Labib; J J Zone; L A Diaz; G J Anhalt
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

Review 10.  Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases.

Authors:  P Bernard
Journal:  Springer Semin Immunopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.